Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity
- PMID: 21377718
- DOI: 10.1016/j.jaci.2011.01.062
Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity
Abstract
Background: The antibody repertoires of allergic subjects are characterized by the presence of allergen-specific IgE antibodies. We have previously shown that the composition of the IgE repertoire is critical for allergen-mediated activation of human effector cells. Activation of CD4(+) T cells in allergic subjects is highly potentiated by the process of facilitated antigen presentation (FAP), in which allergen in complex with IgE is taken up by B cells through the low-affinity IgE receptor CD23 and presented to T cells.
Objective: We sought to investigate the influence of IgE repertoire complexity on the formation of IgE/allergen/CD23 complexes on B cells and subsequent T-cell activation.
Methods: Using defined allergen-specific recombinant IgE and IgG antibodies, we investigated the influence of individual IgE affinity, IgE clonality, specific IgE concentration, and the ratio between IgE specificities on IgE/allergen/CD23 complex formation in vitro.
Results: Although IgE affinity is an important factor, IgE clonality seems to be governing complex formation, especially with medium- and low-affinity IgE antibodies. We demonstrate that differences in allergen-specific IgE affinity correlate with the efficiency of subsequent T-cell activation. In addition, we show that the complexity of an IgE repertoire also affects the ability of allergen-specific IgG antibodies to block FAP.
Conclusion: The composition of allergen-specific IgE repertoires in individual patients, especially with respect to IgE clonality, might play an important role in the manifestation of allergic disease not only for the immediate allergic reaction through activation of basophils and mast cells but also for the exacerbation of allergic inflammation through recurring activation of allergen-specific T cells by FAP.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Similar articles
-
A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.Clin Exp Allergy. 2008 Aug;38(8):1290-301. doi: 10.1111/j.1365-2222.2008.03020.x. Epub 2008 May 28. Clin Exp Allergy. 2008. PMID: 18510696 Clinical Trial.
-
Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.J Immunol. 1999 Sep 1;163(5):2944-52. J Immunol. 1999. PMID: 10453043
-
Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.Immunology. 1995 Nov;86(3):343-50. Immunology. 1995. PMID: 8550069 Free PMC article.
-
IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.Int Arch Allergy Immunol. 2006;141(2):119-29. doi: 10.1159/000094714. Epub 2006 Jul 21. Int Arch Allergy Immunol. 2006. PMID: 16864979 Review.
-
Antibody repertoire complexity and effector cell biology determined by assays for IgE-mediated basophil and T-cell activation.J Immunol Methods. 2012 Sep 28;383(1-2):4-20. doi: 10.1016/j.jim.2012.05.021. Epub 2012 Jun 7. J Immunol Methods. 2012. PMID: 22683539 Review.
Cited by
-
Single-Domain Antibodies-Novel Tools to Study and Treat Allergies.Int J Mol Sci. 2024 Jul 11;25(14):7602. doi: 10.3390/ijms25147602. Int J Mol Sci. 2024. PMID: 39062843 Free PMC article. Review.
-
A Comparison of Natural and Therapeutic Anti-IgE Antibodies.Antibodies (Basel). 2024 Jul 16;13(3):58. doi: 10.3390/antib13030058. Antibodies (Basel). 2024. PMID: 39051334 Free PMC article. Review.
-
IgE and IgG4 Epitopes of Dermatophagoides and Blomia Allergens before and after Sublingual Immunotherapy.Int J Mol Sci. 2023 Feb 20;24(4):4173. doi: 10.3390/ijms24044173. Int J Mol Sci. 2023. PMID: 36835585 Free PMC article.
-
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial.Am J Respir Crit Care Med. 2023 May 1;207(9):1161-1170. doi: 10.1164/rccm.202209-1708OC. Am J Respir Crit Care Med. 2023. PMID: 36701676 Free PMC article. Clinical Trial.
-
Allergen immunotherapy: past, present and future.Nat Rev Immunol. 2023 May;23(5):317-328. doi: 10.1038/s41577-022-00786-1. Epub 2022 Oct 17. Nat Rev Immunol. 2023. PMID: 36253555 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
